Connect Biopharma Limite...

0.68
-0.02 (-2.83%)
At close: Apr 23, 2025, 3:59 PM
0.70
3.52%
After-hours: Apr 23, 2025, 07:59 PM EDT

Connect Biopharma Statistics

Share Statistics

Connect Biopharma has 55.35M shares outstanding. The number of shares has increased by 0.27% in one year.

Shares Outstanding 55.35M
Shares Change (YoY) 0.27%
Shares Change (QoQ) 0%
Owned by Institutions (%) 5.77%
Shares Floating 14.16M
Failed to Deliver (FTD) Shares 857
FTD / Avg. Volume 0.85%

Short Selling Information

The latest short interest is 5.4K, so 0.01% of the outstanding shares have been sold short.

Short Interest 5.4K
Short % of Shares Out 0.01%
Short % of Float 0.02%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -4.88 and the forward PE ratio is -0.28. Connect Biopharma's PEG ratio is 0.07.

PE Ratio -4.88
Forward PE -0.28
PS Ratio 2.93
Forward PS 0.8
PB Ratio 0.83
P/FCF Ratio -3.13
PEG Ratio 0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Connect Biopharma.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.46, with a Debt / Equity ratio of 0.

Current Ratio 11.46
Quick Ratio 11.46
Debt / Equity 0
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $419.89K
Profits Per Employee $-252.06K
Employee Count 62
Asset Turnover 0.26
Inventory Turnover n/a

Taxes

Income Tax 223K
Effective Tax Rate -1.45%

Stock Price Statistics

The stock price has increased by -50.36% in the last 52 weeks. The beta is -0.22, so Connect Biopharma's price volatility has been lower than the market average.

Beta -0.22
52-Week Price Change -50.36%
50-Day Moving Average 0.78
200-Day Moving Average 1.06
Relative Strength Index (RSI) 45.63
Average Volume (20 Days) 101.04K

Income Statement

In the last 12 months, Connect Biopharma had revenue of 26.03M and earned -15.63M in profits. Earnings per share was -0.28.

Revenue 26.03M
Gross Profit 26.03M
Operating Income -22.45M
Net Income -15.63M
EBITDA -22.45M
EBIT -22.45M
Earnings Per Share (EPS) -0.28
Full Income Statement

Balance Sheet

The company has 78.23M in cash and 178K in debt, giving a net cash position of 78.05M.

Cash & Cash Equivalents 78.23M
Total Debt 178K
Net Cash 78.05M
Retained Earnings -345.36M
Total Assets 101.28M
Working Capital 88.5M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.61M and capital expenditures -750K, giving a free cash flow of -24.36M.

Operating Cash Flow -23.61M
Capital Expenditures -750K
Free Cash Flow -24.36M
FCF Per Share -0.44
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -86.24% and -60.03%.

Gross Margin 100%
Operating Margin -86.24%
Pretax Margin -59.17%
Profit Margin -60.03%
EBITDA Margin -86.24%
EBIT Margin -86.24%
FCF Margin -93.58%

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CNTB is $8, which is 1076.5% higher than the current price. The consensus rating is "Buy".

Price Target $8
Price Target Difference 1076.5%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score -4.39
Piotroski F-Score 3